VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NRSNNeuroSense Therapeutics Ltd.
$0.76$19M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNRSNPrice History

NRSN logoNeuroSense Therapeutics Ltd. (NRSN) Stock Price History

Historical prices from 2021 to 2026

$0.76-0.00  (-0.13%)close Jun 25
Returns
1M
-12.9%
3M
-3.0%
YTD
-2.7%
1Y
-65.5%
3Y
-20.8%
5Y
-28.4%
ATH$8.18Mar 2022-90.7%
ATL$0.40Oct 2023pre-split
Avg Vol (50D)142K/ day
52-Week Range$0.63 — $2.28
LowCurrent: $0.76High

Loading 10-year price history...

NRSN Historical Performance

1 YearTotal Return
-67.1%
Price: -65.5%
3 YearsTotal Return
-50.3%
CAGR: -20.8%
Price: -50.4%
5 YearsTotal Return
-81.2%
CAGR: -28.4%
Price: -81.2%
YTD
-2.7%

NRSN Annual Returns

Year-by-year price performance · 2021–2026

Best+50.0%2024
Worst-54.3%2022
Up years2/6
2021-39.1%
2022-54.3%
2023-42.3%
2024+50.0%
2025-33.1%
2026+16.5%
2021 annual price return
-39.1%
2022 annual price return
-54.3%
2023 annual price return
-42.3%
2024 annual price return
+50.0%
2025 annual price return
-33.1%
2026 annual price return
+16.5%
LessMore
Alpha vs S&P 500
1Y-87.9%
3Y-40.4%
5Y-39.8%

Price returns only.

Download Historical Data

1,140 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

NRSN Stock Price Trajectory (2021–2026)

As of June 26, 2026, NeuroSense Therapeutics Ltd. (NRSN) trades at $0.76, representing a -65.5% return over the past year. The stock has delivered a -81.2% total return over five years (-28.4% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $8.18 on March 21, 2022. From this peak, NRSN has corrected -90.7%, currently trading 19% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers PRTA (+54.8% 1Y), ACIU (+18.4% 1Y), and SAVA (-28.6% 1Y), NRSN has underperformed the peer group average. Compare NRSN vs PRTA →

NRSN Historical Price Data · from 2021

Rows 1–50 of 1,140
Date Open High Low Close Volume Change %
2026-06-250.800.800.710.76231K-0.13%
2026-06-240.770.780.750.7656K-1.02%
2026-06-230.770.800.750.77127K-2.69%
2026-06-220.830.900.770.79321K-1.94%
2026-06-180.750.800.740.80219K+14.13%
2026-06-170.700.740.690.7062K+0.86%
2026-06-160.690.730.680.7079K+1.75%
2026-06-150.750.770.670.69297K-6.56%
2026-06-120.750.770.710.74179K-0.51%
2026-06-110.740.740.710.74226K+1.05%
2026-06-100.780.790.720.73133K-3.78%
2026-06-090.820.820.750.76143K+1.12%
2026-06-080.770.810.740.75125K-1.11%
2026-06-050.780.830.730.76102K-2.58%
2026-06-040.780.830.780.78164K-0.04%
2026-06-030.800.840.780.7887K-2.45%
2026-06-020.840.840.780.80115K-1.57%
2026-06-010.850.870.810.8195K-1.05%
2026-05-290.860.900.820.82125K-4.49%
2026-05-280.900.930.860.86126K-6.15%
2026-05-270.870.930.870.92163K+5.10%
2026-05-260.860.880.850.87110K+6.33%
2026-05-220.770.830.770.820+6.08%
2026-05-210.790.830.770.7742K-4.56%
2026-05-200.800.860.760.8171K+6.29%
2026-05-190.780.840.750.76149K-1.08%
2026-05-180.840.870.750.77233K-6.81%
2026-05-150.850.860.820.8342K-2.86%
2026-05-140.850.890.820.8593K+2.21%
2026-05-130.830.830.810.83106K-0.06%
2026-05-120.850.870.830.8342K-0.24%
2026-05-110.870.890.830.8395K-5.11%
2026-05-080.880.900.830.8880K+0.34%
2026-05-070.890.900.860.8848K-2.33%
2026-05-060.980.980.800.90441K-5.46%
2026-05-050.890.950.890.95213K+6.72%
2026-05-040.900.900.880.89152K-0.74%
2026-05-010.830.900.830.90185K+9.21%
2026-04-300.830.830.820.82234K+2.23%
2026-04-290.810.810.760.80141K-0.72%
2026-04-280.800.840.750.81382K+7.78%
2026-04-270.780.780.750.7567K+0.05%
2026-04-240.730.820.720.75207K+4.92%
2026-04-230.730.730.710.7178K+1.79%
2026-04-220.720.730.700.7094K+1.78%
2026-04-210.720.720.680.6995K-2.82%
2026-04-200.700.730.700.71148K+0.42%
2026-04-170.720.740.700.71152K-0.14%
2026-04-160.720.730.700.7197K-3.01%
2026-04-150.730.750.710.73109K+2.82%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NRSN — Frequently Asked Questions

Quick answers to the most common questions about buying NRSN stock.

How has NRSN stock performed recently?

NRSN declined -65.5% over the past year, below its 5-year annualized CAGR of -28.4%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is NRSN's all-time high price?

NeuroSense Therapeutics Ltd. reached $8.18 on 2022-03-21. The 52-week high is $2.28. Current 1-year return of -65.5% places the stock further from historical peaks.

Where can I download NRSN historical price data?

This page provides NRSN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

381 data points · sampled from 1,140